ストックスクリーナーアプリを入手
15.15
2.51%
-0.39
Biodesix Inc (BDSX) 最新ニュース
Is Biodesix (BDSX) stock outpacing its medical peers this year? - MSN
Wall Street analysts see an 86.45% upside in Biodesix (BDSX): Can the stock really move this high? - MSN
If You Invested $1,000 in BIODESIX INC (BDSX) - Stock Titan
Biodesix publishes lung nodule biomarker validation study By Investing.com - Investing.com Australia
Volatility Watch: Can Biodesix Inc expand into new marketsPrice Action & Weekly Momentum Stock Picks - baoquankhu1.vn
Biodesix, Inc.Common Stock (NQ: BDSX - The Chronicle-Journal
Biodesix publishes lung nodule biomarker validation study on 1,100 patients - Investing.com
Biodesix publishes lung nodule biomarker validation study - Investing.com
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis - The Manila Times
Biodesix Publishes Largest Lung Nodule Biomarker Study, Validating Nodify CDT® Test for Lung Cancer Risk Assessment - Quiver Quantitative
Biodesix Announces the Largest Lung Nodule Biomarker - GlobeNewswire
BDSX Stock Price, Quote & Chart | BIODESIX INC (NASDAQ:BDSX) - ChartMill
Is Biodesix (BDSX) Shares Performing Better Than Other Medical Stocks This Year? - Bitget
Wall Street Analysts See an 86.45% Upside in Biodesix (BDSX): Can the Stock Really Move This High? - Yahoo Finance
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is Biodesix (BDSX) Shares Surpassing Other Medical Stocks This Year? - Bitget
Treasury Yields: Can Biodesix Inc navigate macro headwinds2026 Pullbacks & Comprehensive Market Scan Insights - baoquankhu1.vn
Biodesix, Inc. (BDSX) reports Q4 loss, beats revenue estimates - MSN
Wall Street analysts think Biodesix (BDSX) could surge 111.62%: Read this before placing a bet - MSN
Decliners Report: Is Biodesix Inc benefiting from innovation trends2026 Pullbacks & Verified Momentum Stock Alerts - baoquankhu1.vn
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript - MSN
Cannell & Spears LLC Sells 195,326 Shares of Biodesix, Inc. $BDSX - MarketBeat
Biodesix Details Lung Test Momentum, 81% Gross Margin and Growth Plan at Barclays Conference - MarketBeat
Recap Report: What is the dividend yield of Biodesix IncNew Guidance & Accurate Trade Setup Notifications - baoquankhu1.vn
BDSX SEC FilingsBIODESIX INC 10-K, 10-Q, 8-K Forms - Stock Titan
Biodesix Receives 'Moderate Buy' Rating from Analysts - National Today
Biodesix at Barclays Conference: Strategic Growth in Lung Cancer Diagnostics - Investing.com Canada
Biodesix Earnings Call Signals Growth With Caveats - TipRanks
Setup Watch: Is Biodesix Inc in a consolidation phase2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Biodesix Details Lung Nodule Growth Plan, Primary Care Push at TD Cowen Healthcare Conference - MarketBeat
What analysts say about Biodesix Inc stock2025 Dividend Review & Daily Stock Momentum Reports - baoquankhu1.vn
How The Biodesix (BDSX) Investment Story Is Shifting After Guidance And New US$30 Target - Yahoo Finance
Wall Street experts predict that Biodesix (BDSX) may climb by 111.62%: Consider this information before making an investment decision - Bitget
Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet - Finviz
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
BDSX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Are healthcare stocks underperforming Biodesix (BDSX) so far this year? - Bitget
Monashee Investment Management Cuts Biodesix Stake by 95% - National Today
Canaccord reiterates Biodesix stock rating on strong Q4 results By Investing.com - Investing.com Canada
Canaccord reiterates Biodesix stock rating on strong Q4 results - Investing.com
Biodesix (BDSX) Q4 2025 Earnings Call Transcript - AOL.com
Monashee Investment Management LLC Cuts Holdings in Biodesix, Inc. $BDSX - MarketBeat
Q4 2025 Biodesix Inc Earnings Call Transcript - GuruFocus
William Blair Upgrades Biodesix (BDSX) - Nasdaq
William Blair Upgrades BDSX (Biodesix, Inc.) to Outperform Feb 2026 - Meyka
Biodesix (NASDAQ:BDSX) Announces Quarterly Earnings Results, Beats Estimates By $0.56 EPS - MarketBeat
William Blair Upgrades Biodesix (BDSX) to 'Outperform' | BDSX St - GuruFocus
Biodesix expects 2026 sales to crack $100M - BizWest
Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
William Blair Upgrades Biodesix to Outperform From Market Perform - marketscreener.com
GSA Capital Partners LLP Has $365,000 Stake in Biodesix, Inc. $BDSX - MarketBeat
William Blair upgrades Biodesix stock rating on execution momentum By Investing.com - Investing.com Australia
0.19%
0.04%
大文字化:
|
ボリューム (24 時間):